![Jeffrey Almond](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Almond
Direttore/Membro del Consiglio presso iosBio Ltd.
Profilo
Jeffrey Almond is a Non-Executive Director at iosBio Ltd.
He was previously the Chairman at Virion Biotherapeutics Ltd., Director at The Medical Research Council, Principal at The University of Reading, and Vice President-Discovery Research at Sanofi Pasteur Holding SA.
Posizioni attive di Jeffrey Almond
Società | Posizione | Inizio |
---|---|---|
iosBio Ltd.
![]() iosBio Ltd. Packaged SoftwareTechnology Services iosBio Ltd. is a British UK-based biotechnology company that specializes in developing next-generation vaccines that can be administered orally. The company was founded by Jeffrey Drew and is based in Burgess Hill, UK. The company's proprietary orapro™ thermal stabilization technology enables the oral administration of thermally stable, non-replicating viral vectors that can be delivered sublingually via the gastrointestinal tract and other routes. iosBio is developing vaccines designed to stimulate mucosal, systemic, and T-cell immune responses, providing robust immunity to a number of infectious diseases, including COVID-19, Zika, and influenza. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jeffrey Almond
Società | Posizione | Fine |
---|---|---|
Virion Biotherapeutics Ltd.
![]() Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Presidente | - |
Sanofi Pasteur Holding SA
![]() Sanofi Pasteur Holding SA BiotechnologyHealth Technology Sanofi Pasteur Holding SA develops and manufactures vaccines. The company is headquartered in Antony, France. | Direttore Tecnico/Scientifico/R&S | - |
The University of Reading | Corporate Officer/Principal | - |
The Medical Research Council
![]() The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
The Medical Research Council
![]() The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
Sanofi Pasteur Holding SA
![]() Sanofi Pasteur Holding SA BiotechnologyHealth Technology Sanofi Pasteur Holding SA develops and manufactures vaccines. The company is headquartered in Antony, France. | Health Technology |
iosBio Ltd.
![]() iosBio Ltd. Packaged SoftwareTechnology Services iosBio Ltd. is a British UK-based biotechnology company that specializes in developing next-generation vaccines that can be administered orally. The company was founded by Jeffrey Drew and is based in Burgess Hill, UK. The company's proprietary orapro™ thermal stabilization technology enables the oral administration of thermally stable, non-replicating viral vectors that can be delivered sublingually via the gastrointestinal tract and other routes. iosBio is developing vaccines designed to stimulate mucosal, systemic, and T-cell immune responses, providing robust immunity to a number of infectious diseases, including COVID-19, Zika, and influenza. | Technology Services |
Virion Biotherapeutics Ltd.
![]() Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey Almond